182 related articles for article (PubMed ID: 1451334)
1. Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZW x BXSB) F1 mice.
Kawano H; Abe M; Zhang D; Saikawa T; Fujimori M; Hirose S; Shirai T
Clin Immunol Immunopathol; 1992 Dec; 65(3):308-14. PubMed ID: 1451334
[TBL] [Abstract][Full Text] [Related]
2. Causal association between major histocompatibility complex and myocardial infarction in NZW x BXSB F1 mice.
Kawano H; Kawano Y; Shirai T; Okada R
Jpn Circ J; 1995 Feb; 59(2):98-102. PubMed ID: 7596028
[TBL] [Abstract][Full Text] [Related]
3. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.
Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T
Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983
[TBL] [Abstract][Full Text] [Related]
4. The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB)F1 hybrid mice.
Merino R; Iwamoto M; Gershwin ME; Izui S
J Clin Invest; 1994 Aug; 94(2):521-5. PubMed ID: 8040305
[TBL] [Abstract][Full Text] [Related]
5. Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice.
Hirose S; Kinoshita K; Nozawa S; Nishimura H; Shirai T
Int Immunol; 1990; 2(11):1091-5. PubMed ID: 2083229
[TBL] [Abstract][Full Text] [Related]
6. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice.
Merino R; Fossati L; Lacour M; Lemoine R; Higaki M; Izui S
Eur J Immunol; 1992 Feb; 22(2):295-9. PubMed ID: 1537372
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
[TBL] [Abstract][Full Text] [Related]
8. Genetic association between natural autoantibody responses to histones and DNA in murine lupus.
Tokushige K; Kinoshita K; Hirose S; Shirai T
Autoimmunity; 1992; 12(4):285-93. PubMed ID: 1391598
[TBL] [Abstract][Full Text] [Related]
9. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
Kotzin BL; Palmer E
J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
[TBL] [Abstract][Full Text] [Related]
10. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).
Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T
Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913
[TBL] [Abstract][Full Text] [Related]
12. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
[TBL] [Abstract][Full Text] [Related]
13. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.
Izui S; Higaki M; Morrow D; Merino R
Eur J Immunol; 1988 Jun; 18(6):911-5. PubMed ID: 3260184
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease.
Babcock SK; Appel VB; Schiff M; Palmer E; Kotzin BL
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7552-5. PubMed ID: 2571993
[TBL] [Abstract][Full Text] [Related]
15. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice.
Hirose S; Nagasawa R; Sekikawa I; Hamaoki M; Ishida Y; Sato H; Shirai T
J Exp Med; 1983 Jul; 158(1):228-33. PubMed ID: 6864161
[TBL] [Abstract][Full Text] [Related]
17. Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB x NZW)F1 mice.
Hirose S; Tsurui H; Nishimura H; Jiang Y; Shirai T
Int Immunol; 1994 Dec; 6(12):1857-64. PubMed ID: 7696204
[TBL] [Abstract][Full Text] [Related]
18. Resistance to tolerance induction is not prerequisite to development of murine SLE.
Izui S; Masuda K
J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
[TBL] [Abstract][Full Text] [Related]
19. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice.
Nishimura H; Ishikawa S; Nozawa S; Awaji M; Saito J; Abe M; Tokushima M; Kimoto M; Akakura S; Tsurui H; Hirose S; Shirai T
Int Immunol; 1996 Jun; 8(6):967-76. PubMed ID: 8671686
[TBL] [Abstract][Full Text] [Related]
20. Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice.
Noonan DJ; McConahey PJ; Cardenas GJ
Eur J Immunol; 1990 May; 20(5):1105-10. PubMed ID: 1972678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
